ERBB2 and breast carcinoma: Studies from our group and others indicate that the pro-metastatic role of CD151 in human basal-like and ErbB2 breast cancer subtypes is achieved largely through regulating α6 integrin-dependent cell motility, invasion and survival [45,50].